(Q42536315)

1 November 2017

title

Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative (English)

1 reference

1 November 2017

1 reference

Shibata T

1

1 reference

1 November 2017

Matsui K

2

1 reference

1 November 2017

Nagao K

3

1 reference

1 November 2017

Shinkai H

4

1 reference

1 November 2017

Yonemori F

5

1 reference

1 November 2017

Wakitani K

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

European Journal of Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

364

1 reference

1 November 2017

issue

2-3

1 reference

1 November 2017

page(s)

211-219

1 reference

A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

Insulin resistance: a common feature of diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900832-2

10.1016/S0014-2999(98)00832-2

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference